News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Jordan Johnson: Keeping the medical decision discretion in the hands of the Radiation Oncologists
Jordan Johnson/LinkedIn
Nov 4, 2024, 10:43

Jordan Johnson: Keeping the medical decision discretion in the hands of the Radiation Oncologists

Jordan Johnson, Founder and Principal at Bridge Oncology, shared a post on LinkedIn:

“The Final Rule is out:

MPFS 1807-F.

The work by Bridge Oncology, Sean McBride and many others to keep the medical decision discretion in the hands of the Radiation Oncologists.

Strong work!
To see our letter see the link.”

Jordan Johnson: Keeping the medical decision discretion in the hands of the Radiation Oncologists

More posts featuring Jordan Johnson.

Jordan Johnson is the Founding Partner of Bridge Oncology and serves on the Board of Directors for the National Association of Medication Access and Patient Advocacy. He is also the Founder of The Healthcare Hub and LegacybyImpact.

Bridge Oncology cancer Jordan Johnson OncoDaily Oncology radiation oncology Sean McBride
Special Coverage
Insight
Sep 5, 2025, 12:31
Courtney Jones: A New Publication From the Lab in Blood
Voices
Sep 5, 2025, 12:12
Jennifer Sullivan: Bringing "The Best of What We Are Wherever You Are"
Voices
Sep 5, 2025, 12:06
Armando Orlandi: Extraordinary Success for the 17th Breast Club!
Voices
Sep 5, 2025, 11:58
Roupen Odabashian: How WorkDone Health Tackles a $125B Healthcare Problem
Insight
Sep 5, 2025, 11:56
Eric Small on FY26 Budget: Saving Research Means Saving Lives
Voices
Sep 5, 2025, 11:45
Annalice Gandini: A Case Report on the Successful Use of Dual EGFR Blockade
Voices
Sep 5, 2025, 11:43
Conquering Underfunded and Rare Cancers Through Research - Conquer Cancer, the ASCO Foundation
Science
Sep 5, 2025, 11:34
Harpreet Singh: FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant NSCLC
Voices
Sep 5, 2025, 11:26
Jia (Jenny) Liu: Excited to Share that NECTA PANNA-COTA Trial Reaches 100 Patients Enrolled
Voices
Sep 5, 2025, 11:25
Ivana Cattaneo: Excited to Lead European Government Affairs at BeOne Medicines
Voices
Sep 5, 2025, 11:18
Zodwa Dlamini: Advancing Brain Cancer Care: Precision, AI Innovation, and African Insights
Voices
Sep 5, 2025, 11:17
Narjust Florez: Women in Thoracic Oncology Event at WCLC